Dow Up 0.14% Nasdaq Down 0.44%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
30.15 Down 0.27(0.89%) 12:23PM EDT - Nasdaq Real Time Price
Prev Close:30.42
Open:30.53
Bid:30.23 x 100
Ask:30.30 x 200
1y Target Est:39.29
Beta:1.8
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:30.15 - 31.08
52wk Range:27.51 - 39.95
Volume:143,847
Avg Vol (3m):460,338
Market Cap:1.24B
P/E (ttm):69.63
EPS (ttm):0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACOR

Comparison

Symbol% ChgMkt Cap
ACORDown 0.89%1.24B
BIIBDown 0.45%77.58B
TEVADown 0.50%44.52B

Key Statistics

Forward P/E (1 yr):47.25
P/S (ttm):3.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.23
Quarterly EPS Est (Sep-14) :0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):8.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback